News

Company A-Z, Stage of Development, Deal Type, Therapy Focus, and Technology Type

by

DUBLIN, June 21, 2023 /PRNewswire/ — The “Global Drug Delivery Partnering Terms and Agreements 2016-2023” report has been added to ResearchAndMarkets.com’s offering. The Global Drug delivery Partnering Terms and Agreements 2016-2023 report provides unprecedented access to available deals and contract documents for over 1500 drug delivery deals entered into by the worlds leading healthcare companies. This … Read more

Telix to Expand Late-Stage Urologic Pipeline with Acquisition of Lightpoint Medical

by

MELBOURNE, Australia, June 21, 2023 /PRNewswire/ — Telix Pharmaceuticals Limited (ASX: TLX, Telix, the Company) today announces it has entered into an agreement to acquire Lightpoint Medical and its SENSEI® radio-guided surgery business. Lightpoint Medical is a United Kingdom-based medical device company specialising in the intra-operative detection of targeted radiopharmaceuticals. SENSEI is an ultra-miniature robotic gamma probe … Read more

Versameb Appoints Professor Roger Dmochowski as Chief Medical Officer

by

Professor Dmochowski is a world leading key opinion leader in female urology and urologic reconstruction Versameb is accelerating preparations for IND filing of lead candidate VMB-100 BASEL, Switzerland, June 21, 2023 /PRNewswire/ — Versameb AG (“Versameb”), a pre-clinical stage company focused on discovering and developing innovative RNA-based therapeutics, is pleased to announce the appointment of Professor … Read more

Fungi Perfecti Attends The Mushroom Summit Inaugural Event & Demonstrates Activity of Mushroom Mycelium*

by

OLYMPIA, Wash., June 21, 2023 /PRNewswire/ — Fungi Perfecti® – makers of Host Defense® Mushrooms™ – attends The Mushroom Summit inaugural event and demonstrates activity of mushroom mycelium.*  As mushroom supplement category leaders, key Fungi Perfecti staff attend The Mushroom Summit to continue the advancement of the science on mushroom mycelium for human health applications.*†  … Read more

CARESTAR FOUNDATION INVESTS MORE THAN $2 MILLION TO IMPROVE RACIAL EQUITY IN EMERGENCY AND PREHOSPITAL CARE

by

BERKELEY, Calif., June 21, 2023 /PRNewswire/ — The CARESTAR Foundation announced today an investment of more than $2 million in 10 nonprofit organizations that are collectively working to bring greater racial equity to emergency and prehospital care in California. “We are committed to investing in innovative solutions that will help to improve the lives of all … Read more

Dataintelo Releases Comprehensive Report on Global Oral Cancer Diagnostic Market, Forecast 2023-2031

by

PUNE, India, June 21, 2023 /PRNewswire/ — Dataintelo, a leading market research firm, has recently published an in-depth report on the Global Oral Cancer Diagnostic Market. The report sheds light on the current market scenario and provides detailed insights into the market’s growth prospects, dynamics, and competitive landscape. It covers the various diagnostic methods used … Read more

Forecast from 2023 to 2031

by

PUNE, India, June 21, 2023 /PRNewswire/ — Dataintelo, a leading provider of market research and analysis, has announced the release of its latest report on the global robot-assisted surgical system market. The report covers the period from 2023 to 2031 and provides an in-depth analysis of the market’s growth factors, trends, and overall performance. This … Read more

Calliditas Therapeutics Submits Supplemental New Drug Application to U.S. Food and Drug Administration for Full Approval of TARPEYO®

by

STOCKHOLM, June 21, 2023 /PRNewswire/ — Calliditas Therapeutics AB (Nasdaq: CALT) (Nasdaq Stockholm: CALTX) (“Calliditas”) today announced the submission of a supplemental New Drug Application (“sNDA”) to the U.S. Food and Drug Administration (“FDA”) seeking full approval of TARPEYO® (budesonide) delayed release capsules for the entire study population from the Phase 3 NeflgArd study. TARPEYO is … Read more

Calliditas Therapeutics Submits Supplemental New Drug Application to U.S. Food and Drug Administration for Full Approval of TARPEYO®

by

STOCKHOLM, June 21, 2023 /PRNewswire/ — Calliditas Therapeutics AB (Nasdaq: CALT) (Nasdaq Stockholm: CALTX) (“Calliditas”) today announced the submission of a supplemental New Drug Application (“sNDA”) to the U.S. Food and Drug Administration (“FDA”) seeking full approval of TARPEYO® (budesonide) delayed release capsules for the entire study population from the Phase 3 NeflgArd study. TARPEYO is … Read more

Lucile Packard Children’s Hospital Stanford Continues to Rank Among Top Children’s Hospitals in the Nation

by

2023–24 U.S. News & World Report Best Children’s Hospitals annual survey ranks the top pediatric facilities in the country to help families with complex and rare conditions find the best medical care for their children STANFORD, Calif., June 21, 2023 /PRNewswire-HISPANIC PR WIRE/ — Lucile Packard Children’s Hospital Stanford has once again been named the top … Read more